A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52 : A protocol for mixed treatment comparisons meta-analysis

BACKGROUND: According to the centers for disease control and prevention, 14% of American adults have diabetes – 10% know it, and more than 4% go undiagnosed. Sotagliflozin is a new type of diabetes drug This study is to compare the efficacy of Sotagliflozin therapy for Diabetes Mellitus (DM) between...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Nie, Gu, Zhi-Qun, Ding, Yun-Long, Yang, Liu, Chen, Mao-Bing, Zheng, Qi-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882651/
https://www.ncbi.nlm.nih.gov/pubmed/31764805
http://dx.doi.org/10.1097/MD.0000000000017976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882651/
https://www.ncbi.nlm.nih.gov/pubmed/31764805
http://dx.doi.org/10.1097/MD.0000000000017976

Ejemplares similares